Meanwhile, the rapamycin specificity inhibited the expression of mTOR and upregulated the beclin-1 level to improve neuroprotective effects in ischemia reperfusion injury (169), where beclin-1 will stimulate the macrophage autophagy in the brain (247, 248). The gene discussed is BECN1; the disease is ischemia reperfusion injury.